90% of biologic drugs expiring by 2034 lack alternatives, report says
AI Summary- Association for Accessible Medicines reported that most biologic drugs nearing patent expiration lack alternatives in development.
- Ninety percent of affected drugs have no lower-cost alternatives, involving 118 popular biologic medicines.
- The association estimates nearly $200 billion in healthcare savings could be missed over the next decade.